These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34551288)

  • 1. Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for T cell activation.
    Zhao M; Fu L; Chai Y; Sun M; Li Y; Wang S; Qi J; Zeng B; Kang L; Gao GF; Tan S
    Cell Rep; 2021 Sep; 36(12):109734. PubMed ID: 34551288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of mouse and human GITR-GITRL complexes reveal unique TNF superfamily interactions.
    Wang F; Chau B; West SM; Kimberlin CR; Cao F; Schwarz F; Aguilar B; Han M; Morishige W; Bee C; Dollinger G; Rajpal A; Strop P
    Nat Commun; 2021 Mar; 12(1):1378. PubMed ID: 33654081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR).
    Platania CBM; Ronchetti S; Riccardi C; Migliorati G; Marchetti MC; Di Paola L; Lazzara F; Drago F; Salomone S; Bucolo C
    Biochem Pharmacol; 2020 Aug; 178():114110. PubMed ID: 32569630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality.
    Richards DM; Marschall V; Billian-Frey K; Heinonen K; Merz C; Redondo Müller M; Sefrin JP; Schröder M; Sykora J; Fricke H; Hill O; Gieffers C; Thiemann M
    J Immunother Cancer; 2019 Jul; 7(1):191. PubMed ID: 31324216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of GITRL immune function: murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily.
    Chattopadhyay K; Ramagopal UA; Brenowitz M; Nathenson SG; Almo SC
    Proc Natl Acad Sci U S A; 2008 Jan; 105(2):635-40. PubMed ID: 18182486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system.
    Kobayashi Y; Kiguchi N; Fukazawa Y; Saika F; Maeda T; Kishioka S
    J Biol Chem; 2015 May; 290(20):12603-13. PubMed ID: 25787078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological role of GITR/GITRL in attributes and immune responses of macrophage.
    Fu Z; Wang S; Li J; Zhang Y; Li H; Li G; Wan X; Zhang Y
    J Leukoc Biol; 2020 Feb; 107(2):309-321. PubMed ID: 31833599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
    Nocentini G; Ronchetti S; Petrillo MG; Riccardi C
    Br J Pharmacol; 2012 Apr; 165(7):2089-99. PubMed ID: 22029729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for ligand-mediated mouse GITR activation.
    Zhou Z; Tone Y; Song X; Furuuchi K; Lear JD; Waldmann H; Tone M; Greene MI; Murali R
    Proc Natl Acad Sci U S A; 2008 Jan; 105(2):641-5. PubMed ID: 18178614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory.
    Durham NM; Holoweckyj N; MacGill RS; McGlinchey K; Leow CC; Robbins SH
    J Immunother Cancer; 2017; 5():47. PubMed ID: 28649380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th2 responses to helminth parasites can be therapeutically enhanced by, but are not dependent upon, GITR-GITR ligand costimulation in vivo.
    van der Werf N; Redpath SA; Phythian-Adams AT; Azuma M; Allen JE; Maizels RM; Macdonald AS; Taylor MD
    J Immunol; 2011 Aug; 187(3):1411-20. PubMed ID: 21705620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GITR-GITRL system, a novel player in shock and inflammation.
    Krausz LT; Bianchini R; Ronchetti S; Fettucciari K; Nocentini G; Riccardi C
    ScientificWorldJournal; 2007 May; 7():533-66. PubMed ID: 17525820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GITRL on inflammatory antigen presenting cells in the lung parenchyma provides signal 4 for T-cell accumulation and tissue-resident memory T-cell formation.
    Chu KL; Batista NV; Wang KC; Zhou AC; Watts TH
    Mucosal Immunol; 2019 Mar; 12(2):363-377. PubMed ID: 30487647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced tumor necrosis factor receptor family-related ligand triggering upregulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 and promotes leukocyte adhesion.
    Lacal PM; Petrillo MG; Ruffini F; Muzi A; Bianchini R; Ronchetti S; Migliorati G; Riccardi C; Graziani G; Nocentini G
    J Pharmacol Exp Ther; 2013 Oct; 347(1):164-72. PubMed ID: 23892569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of GITR/GITRL Interaction in Autoimmune Diseases.
    Tian J; Zhang B; Rui K; Wang S
    Front Immunol; 2020; 11():588682. PubMed ID: 33163004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of acute and chronic inflammation of the lung by GITR and its ligand.
    Nocentini G; Cuzzocrea S; Bianchini R; Mazzon E; Riccardi C
    Ann N Y Acad Sci; 2007 Jun; 1107():380-91. PubMed ID: 17804566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells.
    Yu KY; Kim HS; Song SY; Min SS; Jeong JJ; Youn BS
    Biochem Biophys Res Commun; 2003 Oct; 310(2):433-8. PubMed ID: 14521928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma.
    Chan M; Wu L; Yun Z; McKee TD; Cabanero M; Zhao Y; Kohno M; Murakami J; de Perrot M
    Commun Biol; 2021 Jul; 4(1):914. PubMed ID: 34312483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions.
    Baltz KM; Krusch M; Bringmann A; Brossart P; Mayer F; Kloss M; Baessler T; Kumbier I; Peterfi A; Kupka S; Kroeber S; Menzel D; Radsak MP; Rammensee HG; Salih HR
    FASEB J; 2007 Aug; 21(10):2442-54. PubMed ID: 17360848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted.
    Kim YH; Shin SM; Choi BK; Oh HS; Kim CH; Lee SJ; Kim KH; Lee DG; Park SH; Kwon BS
    J Immunol; 2015 Nov; 195(10):4721-9. PubMed ID: 26423152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.